Related Experiment Video

Updated: Aug 14, 2026

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
09:43

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice

Published on: June 8, 2022

C1q complement component and -antibodies reflect SLE activity and kidney involvement

P Horák1, Z Hermanová, J Zadrazil

  • 13rd Department of Internal Medicine, Faculty of Medicine, Palacký University of Olomouc, I. P. Pavlova 6, 772 00, Olomouc, Czech Republic. horakp@fnol.cz

Clinical Rheumatology
|November 29, 2005
PubMed

Insights

Anti-C1q antibodies and C1q levels in systemic lupus erythematosus (SLE) patients show a mirror-like pattern. Elevated anti-C1q antibodies and decreased C1q levels correlate with active disease and lupus nephritis.

Area of Science:

  • Immunology
  • Rheumatology
  • Systemic Autoimmune Diseases

Background:

  • The complement system plays a complex role in systemic diseases like systemic lupus erythematosus (SLE).
  • Abnormalities in complement activation are frequently observed in SLE patients.
  • Anti-C1q antibodies are significant autoantibodies associated with SLE pathogenesis.

Purpose of the Study:

  • To evaluate serum levels of anti-C1q antibodies and the C1q complement component in SLE patients.
  • To assess these markers in relation to lupus nephritis and disease activity (ECLAM).
  • To explore correlations between anti-C1q antibodies, C1q levels, and clinical/laboratory parameters.

Main Methods:

  • Serum samples from 65 SLE patients were analyzed.
  • Anti-C1q antibodies were quantified using Enzyme-Linked Immunosorbent Assay (ELISA).
  • C1q complement component levels were measured by radial immunodiffusion (Mancini method).

Main Results:

  • Significant differences in anti-C1q antibody levels were found between patients with and without lupus nephritis (p=0.0001) and between active and nonactive SLE (p=0.001).
  • C1q complement component levels were significantly lower in patients with lupus nephritis (p=0.002) and active SLE (p=0.001).
  • Anti-C1q antibodies and C1q levels exhibited an inverse relationship, suggesting a mirror-like pattern.

Conclusions:

  • Anti-C1q antibodies and C1q levels serve as potential biomarkers for SLE activity.
  • These markers may indicate the presence and severity of lupus nephritis.
  • The inverse correlation suggests a dynamic interplay between C1q consumption and antibody formation in SLE.

More Related Videos

Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells06:29

Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells

Published on: January 29, 2014

Related Concept Videos

Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Complement System01:27

Complement System

The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a membrane...
Hypersensitivity Reactions: Immune-Complex Reactions01:19

Hypersensitivity Reactions: Immune-Complex Reactions

Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum sickness, a systemic...
Hypersensitivity Reactions: Cytolytic Reactions01:01

Hypersensitivity Reactions: Cytolytic Reactions

Type II hypersensitivity involves IgG and IgM antibodies targeting cell surface antigens, leading to cell destruction. This can occur through complement activation, antibody-dependent cell-mediated cytotoxicity (ADCC), or acting as opsonins for phagocytosis. When excessive, these reactions cause significant tissue damage.Drug-induced hemolytic anemia is a common example, where drugs like penicillin or cephalosporins bind to red blood cells, forming drug-protein complexes. These complexes...